(Q33841399)

English

Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

Europe PubMed Central

Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

systematic review

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Selim Aractingi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Hervé Bachelez

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

A Gallini

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

A Maza

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

H Montaudié

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

E Sbidian

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

F Aubin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

B Cribier

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

P Joly

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

D Jullien

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

M Le Maître

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

L Misery

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

M-A Richard

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

J-P Ortonne

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

25 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

2-11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Increasing use of more potent treatments for psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Methotrexate in psoriasis: consensus conference

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Ciclosporin in psoriasis clinical practice: an international consensus statement

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Efficacy and safety of oral retinoids in different psoriasis subtypes: a systematic literature review.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Updated method guidelines for systematic reviews in the cochrane collaboration back review group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Long-term continuous versus intermittent cyclosporin: therapy for psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

A prospective study of renal structure and function in psoriasis patients treated with cyclosporin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

A 12-month treatment of severe psoriasis with acitretin: Results of a Canadian open multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Clinical efficacy and side effects of acitretin on the disorders of keratinization: a one-year study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

High-dose treatment with vitamin A analogues and risk of fractures.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

A comparison of PUVA-etretinate and PUVA-placebo for palmoplantar pustular psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Acitretin therapy for palmoplantar pustulosis combined with UVA and topical 8-MOP.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

The effect of etretinate compared with different regimens of PUVA in the treatment of persistent palmoplantar pustulosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Evaluation of the efficacy of acitretin therapy for nail psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Pustular psoriasis of the nails: treatment and long-term follow-up of 46 patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Impact of quality of evidence on the strength of recommendations: an empirical study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Curricula for teaching the content of clinical practice guidelines to family medicine and internal medicine residents in the US: a survey study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Evidence-based clinical guidelines: a new system to better determine true strength of recommendation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Double-blind placebo-controlled study of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2011.03990.X

21 January 2018

Identifiers

10.1111/J.1468-3083.2011.03990.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21388453%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33841399&oldid=1533454809"